Correlation between lncRNA HCG11 mRNA and miR-4465 Expression Levels and Clinicopathological Features and Prognosis in Triple-negative Breast Cancer Tissues
10.3969/j.issn.1671-7414.2025.01.016
- VernacularTitle:三阴性乳腺癌组织中lncRNA HCG11 mRNA和miR-4465水平表达与临床病理特征及预后的相关性研究
- Author:
Ling ZHANG
1
;
Haiyan XU
1
;
Qiangli WANG
1
;
Yijin YANG
1
;
Bin CHEN
1
Author Information
1. 苏州市九龙医院肿瘤内科,江苏苏州 215021
- Publication Type:Journal Article
- Keywords:
triple-negative breast cancer;
long non-coding RNA HCG11;
miR-4465
- From:
Journal of Modern Laboratory Medicine
2025;40(1):84-89
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression and clinical significance of long non-codingRNA HCG11 (lncRNA HCG11) mRNA and microRNA (miR)-4465 in patients with triple-negative breast cancer(TNBC). Methods The clinicopathological data of 110 TNBC patients hospitalized in Jiulong Hospital of Suzhou from June 2017 to June 2020 were collected,and the clinical significance of the expression of lncRNA HCG11mRNA and miR-4465 was analyzed. Results The expression of lncRNA HCG11 mRNA (1.81±0.53) in cancer tissues was higher than that in adjacent tissues (0.87±0.13),while the expression of miR-4465 (0.68±0.14) was lower than that in adjacent tissues (1.09±0.18),and the differences were statistically significant(t=18.066,18.857,all P<0.05). The results of Pearson analysis showed that lncRNA HCG11mRNA was negatively correlated with the expression of miR-4465 (r=-0.443,P<0.001). The proportion of patients with high expression of lncRNA HCG11mRNA and low expression of miR-4465 in cancer tissues with lymph node metastasis in TNM stage Ⅲ+Ⅳ was higher than that in TNM stage Ⅰ+Ⅱ,and the proportion of patients without lymph node metastasis was higher (x2=6.614,18.510;8.093,22.976,all P<0.05) The 3-year survival rate of lncRNA HCG11mRNA patients with high expression was lower than that of lncRNA HCG11mRNA patients with low expression,and the 3-year survival rate of patients with high expression of miR-4465 was higher than that of patients with low expression of miR-4465 (Log-rank x2=14.45,13.39,all P<0.05). The proportion of patients with clinical stage Ⅲ+Ⅳ in death group was higher than that in survival group (x2=12.667,18.026,all P<0.05). LncRNA HCG11mRNA(HR=2.623,95％CI:1.344～5.118) was risk factors for 3-year death in TNBC patients,while miR-4465(HR=0.891,95％CI:0.821～0.967) was a protective factor (P<0.05). Conclusion The high expression of lncRNA HCG11 mRNA and the low expression of miR-4465 in triple negatire breast cancer were related to the clinicopathological characteristics and prognosis of patients,and are expected to become prognostic marker for TNBC.
